Simplified Switching to Once‐Weekly Insulin Icodec Without an Initial One‐Time Additional Dose Versus Once‐Daily Insulin Glargine U100 in Basal Insulin‐Treated Type 2 Diabetes ( ONWARDS 10): A Randomised Controlled Trial
Fuente:
Wiley Open Access
Saved in:
| Main Authors: | Julio Rosenstock, Chantal Mathieu, Joshua Buron Feinberg, Priyanka Rao, Cathrine Scavenius, Alice Y. Y. Cheng |
|---|---|
| Format: | Artículo Open Access |
| Published: |
Wiley
2026
|
| Subjects: | |
| Online Access: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
Clinical Outcomes With Once‐Weekly Insulin Icodec Versus Once‐Daily Insulin Glargine U100 in Insulin‐Naïve and Previously Insulin‐Treated Individuals With Type 2 Diabetes: A Meta‐Analysis of Randomised Controlled Trials
by: Mushood Ahmed, et al.
Published: (2024)
by: Mushood Ahmed, et al.
Published: (2024)
Once‐Weekly Insulin Versus Once‐Daily Insulin for Type 1 Diabetes Treatment: A Systematic Review and Meta‐Analysis of Randomised Controlled Trials
by: Obieda Altobaishat, et al.
Published: (2025)
by: Obieda Altobaishat, et al.
Published: (2025)
Glycaemic Control According to the Final Insulin Dose Using an Innovative Fixed‐Dose Titration of Weekly Insulin Efsitora in Insulin‐Naïve Type 2 Diabetes
by: Lisa Connery, et al.
Published: (2026)
by: Lisa Connery, et al.
Published: (2026)
Efficacy and Safety of Once‐Weekly and Once‐Daily Basal Insulins in Type 1 Diabetes Mellitus: A Systematic Review and Network Meta‐Analysis of Clinical Trials
by: Ricardo Amaral, et al.
Published: (2026)
by: Ricardo Amaral, et al.
Published: (2026)
Se‐Glargine: Chemical Synthesis of a Basal Insulin Analogue Stabilized by an Internal Diselenide Bridge
by: Orit Weil‐Ktorza, et al.
Published: (2024)
by: Orit Weil‐Ktorza, et al.
Published: (2024)
The Silver Jubilee (2025) of Insulin Glargine: Introducing the Era of Long‐Acting Insulin Analogues for Diabetes Mellitus
by: Geremia B. Bolli, et al.
Published: (2026)
by: Geremia B. Bolli, et al.
Published: (2026)
Long‐Term Effectiveness of Once‐Weekly Semaglutide in Patients With Type 2 Diabetes Previously Treated With Insulin. A Multicentre Real‐World Study
by: Benedetta Maria Bonora, et al.
Published: (2025)
by: Benedetta Maria Bonora, et al.
Published: (2025)
Efficient Extracellular Production of Insulin Glargine in Trichoderma reesei by an Integrative Secretion‐Based Strategy
by: Aiqin Yan, et al.
Published: (2026)
by: Aiqin Yan, et al.
Published: (2026)
Exogenous Insulin Antibody Syndrome: An Overlooked Cause of Severe Hypoglycemia and Insulin Resistance in a Patient With Type 2 Diabetes Treated With Insulin
by: Kazuki Miyaue, et al.
Published: (2025)
by: Kazuki Miyaue, et al.
Published: (2025)
Caffeine Inhibits Both Basal and Insulin‐Activated Urate Transport
by: Asim K. Mandal, et al.
Published: (2024)
by: Asim K. Mandal, et al.
Published: (2024)
Once‐weekly insulin icodec compared with daily basal insulin analogues in type 2 diabetes: Participant‐level meta‐analysis of the ONWARDS 1–5 trials
by: Harpreet S. Bajaj, et al.
Published: (2024)
by: Harpreet S. Bajaj, et al.
Published: (2024)
Journal of Insulin Resistance
Published: (2017)
Published: (2017)
Myocardial Insulin Resistance
by: de Oliveira Andrade, Luis Jesuino, et al.
Published: (2021)
by: de Oliveira Andrade, Luis Jesuino, et al.
Published: (2021)
Glucocorticoid‐Induced Hyperglycaemia in Hospital: The Insulin Dose Matters Most
by: Morton G. Burt, et al.
Published: (2026)
by: Morton G. Burt, et al.
Published: (2026)
In Response to: High Dose Insulin Is an Inodilator, Not an Antidote in the Poisoned Patient!
by: Daniel Tirado, et al.
Published: (2025)
by: Daniel Tirado, et al.
Published: (2025)
Comparative Effectiveness of Switching From First‐Generation Basal Insulins to Either Glargine 300 U/mL or Degludec 100 U/mL in Children and Adolescents With Type 1 Diabetes: Results From the ISPED CARD Clinical Registry
by: Ivana Rabbone, et al.
Published: (2025)
by: Ivana Rabbone, et al.
Published: (2025)
Introduction of Diabetes Mellitus and Insulin
by: Sandeep R Kulkarni, et al.
Published: (2022)
by: Sandeep R Kulkarni, et al.
Published: (2022)
On the Observation of Glucose–Insulin Models
by: Klaus Röbenack, et al.
Published: (2024)
by: Klaus Röbenack, et al.
Published: (2024)
Personalised Insulin Adjustment with Reinforcement Learning: An In-Silico Validation for People with Diabetes on Intensive Insulin Treatment
by: Panagiotou, Maria, et al.
Published: (2025)
by: Panagiotou, Maria, et al.
Published: (2025)
Evaluation of New‐Modelled Recombinant Human Insulin (rh‐Insulin) Analog Expressed in E. coli Using Radioiodination Technique Followed by In Vivo Biodistribution in Diabetes‐Induced Mice
by: Gamal Abdelaziz, et al.
Published: (2025)
by: Gamal Abdelaziz, et al.
Published: (2025)
Evaluating Intensive Insulin Therapy With Empagliflozin in Type 2 Diabetes: A Randomised Study
by: Nobutoshi Fushimi, et al.
Published: (2025)
by: Nobutoshi Fushimi, et al.
Published: (2025)
Attention Networks for Personalized Mealtime Insulin Dosing in People with Type 1 Diabetes
by: Fathi, Anas El, et al.
Published: (2024)
by: Fathi, Anas El, et al.
Published: (2024)
A Review On Insulin Pump Therapy
by: Khushi V. Kayande, et al.
Published: (2026)
by: Khushi V. Kayande, et al.
Published: (2026)
Towards the Development of an Insulin Degradation Test
by: David Ritz, et al.
Published: (2026)
by: David Ritz, et al.
Published: (2026)
Insulin Requirement Profiles of Short‐Term Continuous Subcutaneous Insulin Infusion Therapy in Patients With Type 2 Diabetic Nephropathy
by: Qianqiu Feng, et al.
Published: (2025)
by: Qianqiu Feng, et al.
Published: (2025)
Insulin receptor responsiveness governs TGFβ ‐induced hepatic stellate cell activation: Insulin resistance instigates liver fibrosis
by: Wang‐Hsin Lee, et al.
Published: (2025)
by: Wang‐Hsin Lee, et al.
Published: (2025)
The Role of Insulin Sensitivity in Lean Mass Changes During Weight Loss With or Without Exercise
by: Ciera L. Bartholomew, et al.
Published: (2025)
by: Ciera L. Bartholomew, et al.
Published: (2025)
Sixfold Symmetry in Biomolecules: From Insulin to Eumelanins.
by: Okolo, Hanyelichukwu Paul
Published: (2025)
by: Okolo, Hanyelichukwu Paul
Published: (2025)
Insulin resistance and periodontitis: Mediation by blood pressure
by: Ashish C. Kalhan, et al.
Published: (2024)
by: Ashish C. Kalhan, et al.
Published: (2024)
Chemical Modification of Insulin Using Flow Chemistry
by: Haoyu Chen, et al.
Published: (2024)
by: Haoyu Chen, et al.
Published: (2024)
Spotlight commentary—Insulin therapy: Future directions
by: Ana Deškin, et al.
Published: (2025)
by: Ana Deškin, et al.
Published: (2025)
Combinatorial Libraries of Bipodal Binders of the Insulin Receptor
by: Irena Selicharová, et al.
Published: (2024)
by: Irena Selicharová, et al.
Published: (2024)
Investigating the Correlation Between Cognitive Function and Fasting Blood Sugar, Fasting Insulin Level and Insulin Sensitivity in Patients With Multiple Sclerosis
by: Nasim Rezaeimanesh, et al.
Published: (2024)
by: Nasim Rezaeimanesh, et al.
Published: (2024)
Triple Calcium Binding Stoichiometry in the Monoclinic Crystal Form of Protracted Insulin
by: Esra Ayan, et al.
Published: (2025)
by: Esra Ayan, et al.
Published: (2025)
Effects of a Circuit Training Program on Myokine Levels in Insulin‐Resistant Women: A Randomised Controlled Trial
by: Joanna Karolkiewicz, et al.
Published: (2024)
by: Joanna Karolkiewicz, et al.
Published: (2024)
Future of Closed-Loop Insulin Delivery: Advances and Prospects
by: Rohini Kawale
Published: (2026)
by: Rohini Kawale
Published: (2026)
Insulin‐Related Disordered Eating Behavior: Clarifying Terminology
by: Amy Shelford, et al.
Published: (2025)
by: Amy Shelford, et al.
Published: (2025)
Wearable Thermoelectric Generators for In Vivo Modulation of Insulin Release
by: Debasis Maity, et al.
Published: (2025)
by: Debasis Maity, et al.
Published: (2025)
DIETS: Diabetic Insulin Management System in Everyday Life
by: Zeng, Hanyu, et al.
Published: (2024)
by: Zeng, Hanyu, et al.
Published: (2024)
Mechanism of Insulin Emission in Matrix Assisted Laser Ionization
by: F. Fernández-Lima
Published: (2005)
by: F. Fernández-Lima
Published: (2005)
Similar Items
-
Clinical Outcomes With Once‐Weekly Insulin Icodec Versus Once‐Daily Insulin Glargine U100 in Insulin‐Naïve and Previously Insulin‐Treated Individuals With Type 2 Diabetes: A Meta‐Analysis of Randomised Controlled Trials
by: Mushood Ahmed, et al.
Published: (2024) -
Once‐Weekly Insulin Versus Once‐Daily Insulin for Type 1 Diabetes Treatment: A Systematic Review and Meta‐Analysis of Randomised Controlled Trials
by: Obieda Altobaishat, et al.
Published: (2025) -
Glycaemic Control According to the Final Insulin Dose Using an Innovative Fixed‐Dose Titration of Weekly Insulin Efsitora in Insulin‐Naïve Type 2 Diabetes
by: Lisa Connery, et al.
Published: (2026) -
Efficacy and Safety of Once‐Weekly and Once‐Daily Basal Insulins in Type 1 Diabetes Mellitus: A Systematic Review and Network Meta‐Analysis of Clinical Trials
by: Ricardo Amaral, et al.
Published: (2026) -
Se‐Glargine: Chemical Synthesis of a Basal Insulin Analogue Stabilized by an Internal Diselenide Bridge
by: Orit Weil‐Ktorza, et al.
Published: (2024)